Organization and Basis of Presentation - Summary of Company's Consolidated Statements of Operations (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Sales	$ 30,893	$ 37,895
Cost of sales	7,395	9,566
Gross profit	23,498	28,329
Operating Expenses [Abstract]
Total operating expenses	41,327	39,003
Loss from operations	(17,829)	(10,674)
Nonoperating Income (Expense) [Abstract]
Interest expense	(3)	(6)
Interest and other income	1,954	2,508
Loss before income taxes	(15,878)	(8,172)
Income tax expense	6	18
Net Income (Loss)	(15,884)	(8,190)
Commercial [Member]
Operating Expenses [Abstract]
Total operating expenses	20,210	21,174
General and Administrative [Member]
Operating Expenses [Abstract]
Total operating expenses	11,645	7,462
Research and Development [Member]
Operating Expenses [Abstract]
Total operating expenses	7,836	9,056
Clinical and Regulatory [Member]
Operating Expenses [Abstract]
Total operating expenses	$ 1,636	$ 1,311